Holdings
Artia Global Partners LP
As of Sep 30, 2026, Artia Global Partners LP reported 45 positions worth US$439M. Largest: Insmed Incorporated, Revolution Medicines, Inc. and Abivax SA. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Insmed Incorporated | 589K | US$67.2M | no change | Sep 30, 2026 |
| Revolution Medicines, Inc. | 185K | US$38.1M | no change | Sep 30, 2026 |
| Abivax SA | 364K | US$36.1M | −152K | Sep 30, 2026 |
| BrightSpring Health Services, Inc. | 610K | US$34.6M | +92,629 | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 2.21M | US$31.7M | no change | Sep 30, 2026 |
| argenx SE | 29,739 | US$28.5M | no change | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 398K | US$23.5M | +59,460 | Sep 30, 2026 |
| Guardant Health, Inc. | 96,704 | US$17.2M | +58,604 | Sep 30, 2026 |
| Quest Diagnostics Incorporated | 65,122 | US$15.2M | no change | Sep 30, 2026 |
| Dianthus Therapeutics, Inc. | 166K | US$14.6M | +2,745 | Sep 30, 2026 |